Equillium Receives FDA Clearance of COVID-19 IND for Phase 3 Trial Equillium plans to initiate global Phase 3 COVID-19 trial – EQUINOX – during Q4 2020 FDA indicates study could support BLA filing LA JOLLA, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Equillium,...

Clinical Trial Shows Itolizumab Reduces Mortality in Patients Hospitalized with COVID-19 Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon Biocon has received emergency use approval from Drugs Controller General of...